Improving Cancer Prevention and Control Through Academic-local Public Health Department Partnerships
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Sep 17, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving cancer prevention and control by studying how partnerships between academic institutions and local public health departments can help put effective cancer programs and policies into action. The goal is to find better ways to use these partnerships to support communities in fighting cancer.
To be eligible for this study, participants should be local health department workers involved in cancer prevention programs or employees from academic institutions that collaborate with health departments. This study is currently active but not recruiting new participants. While individuals aged 18 and older can take part, those under 18 are not eligible. Participants can expect to share their experiences and insights about how these partnerships work and how they can be improved to benefit cancer prevention efforts in their communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Local health department practitioners who are involved in the implementation of cancer prevention and control programs within their communities and are engaged in an academic-health department partnership.
- • Employees in academic settings currently partnering with local health departments. These partnerships could be located anywhere within the United States.
- Exclusion Criteria:
- • • Individuals under the age of 18 years old.
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
St. Louis, Missouri, United States
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Stephanie Mazzucca-Ragan
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported